Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Jiangbo Pharmaceuticals has appointed Linxian Jin as its new CEO effective July 1, 2010, as part of an effort to continue to strengthen the senior management team. Mr Jin will succeed Wubo Cao, who resigned on June 29, 2010.
Subscribe to our email newsletter
Mr Cao is expected to continue his role as the chairman of the company’s board.
Earlier, in April 2008, Mr Jin joined Laiyang Jiangbo Pharmaceuticals, the wholly owned subsidiary of Jiangbo Pharmaceuticals, as deputy general manager of Production Technology.
Previously, he has served as general manager of Shandong Luxi Pharmacy and deputy general manager of Shandong Quancheng Pharmaceutical from October 2000 to June 2006. Mr Jin was also deputy general manager of Zibo Hualong Pharmaceutical and Linuo Group Jinan Yongning Pharmaceutical.
Mr Jin said: “I am delighted to join Jiangbo. Together with the rest of Jiangbo’s management team, I plan to work hard to better define and execute a strategic plan that maximizes Jiangbo’s growth potential and returns value to our shareholders.”
Mr Cao said: “On behalf of the board, I welcome Mr Linxian Jin as the new CEO of Jiangbo at a critical turning point in the company’s development when we require a deeper senior management team to achieve our strategic objectives.
“Mr Jing brings considerable experience and leadership to Jiangbo and I believe that he is well-qualified to guide the company through the next chapter of its growth.”
Jiangbo Pharmaceuticals is engaged in the research, development, production, marketing and sales of pharmaceutical products in China.